-
Oct 12, 2022, 1:17 pm135 pts
Ars Technica
Enlarge / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake Worth, Florida. (credit: Getty | Joe Raedle) The nasal version of the Oxford/AstraZeneca COVID-19 vaccine failed an early-stage clinical trial, dashing hopes for better infection prevention and forcing…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.



















